SULFs in human neoplasia: implication as progression and prognosis factors.
about
CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.The glycome of normal and malignant plasma cellsKnockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cisRestoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosisSULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.Novel therapeutic targets in the brain tumor microenvironmentNovel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cellsSULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study.Role of heparan sulfatases in ovarian and breast cancer.Involvement of SULF2 in y-irradiation-induced invasion and resistance of cancer cells by inducing IL-6 expression.Heparan sulfate and heparanase as modulators of breast cancer progressionImpact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signalingExpression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neckA spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasis.The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumorsPost-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer.The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.Glycosylation alterations in lung and brain cancer.Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tractSULF1/SULF2 reactivation during liver damage and tumour growth.Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma.Proteoglycans as potential microenvironmental biomarkers for colon cancer.Over-expression of human endosulfatase-1 exacerbates cadmium-induced injury to transformed human lung cells in vitro.HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells.Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling.
P2860
Q30829189-DA067BF8-61EC-4D3E-9A91-9F7400C627ABQ35080602-4BDA84F3-2D13-47D2-BEE2-B511DCA27374Q35084936-3E7FC79A-AC7F-4F62-8A00-C88515239AADQ35903837-E287055F-BDE5-4928-9715-DB98C0EB7651Q35925048-2F16A223-8287-4520-906E-888A720EDFA7Q36071884-977B0097-9BA0-4BB1-809A-D8811261D875Q36354021-A31DBDB0-5543-4ACC-8156-F46870404ACBQ36496211-8212BC5F-ACDB-4A9B-BC10-9FD4DBD46445Q36562888-CB1BC4A0-BF67-408E-8192-31F1B22D49E0Q37085960-80617C77-E2B4-4F03-96CD-17A746D25607Q37105315-F8BCAB09-6D8E-436A-B2E9-A4746BF0B7ACQ37462495-2BB7D1E5-8294-49FF-841A-B5E4C46B574FQ37467900-E85E23FA-C42A-42CB-82E1-D0F6BAD12024Q37536514-CE83EAC6-8568-4D0B-BC42-691E31B85EBCQ37943014-3C8A12E9-336B-4BED-A906-A98FBEB5599CQ38176008-3FA72B0C-D525-4C2E-AF79-DC1D9AEFE9C8Q38181492-47EBA559-286F-41F0-B461-6DDCA2A395DDQ38238094-FCBE94E4-B9F5-47F6-BFD5-2B6A179D1AFAQ38366332-0E2E1383-C4B2-4019-9A32-DE3180ECAAB5Q38774630-12862E9F-E8A5-4043-889E-70C290265607Q38783242-805059FC-2F4B-411C-A46F-03E6EA052EF4Q38806342-9AE52229-1FC7-4755-B76D-D3241656681FQ38906085-45C137A1-B91F-470E-A2D6-D588FF8B324EQ39273931-1152240C-6A50-4F39-9AC1-6A1FA4C0C3ACQ39300738-9F68EBCE-8E4E-48B5-823A-C84CC55436FFQ47102962-5C1E9D43-ABB9-404D-97E4-0DB10C58357BQ51706240-F9F1A11C-5292-47A5-A160-8227F530512C
P2860
SULFs in human neoplasia: implication as progression and prognosis factors.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
SULFs in human neoplasia: implication as progression and prognosis factors.
@en
SULFs in human neoplasia: implication as progression and prognosis factors.
@nl
type
label
SULFs in human neoplasia: implication as progression and prognosis factors.
@en
SULFs in human neoplasia: implication as progression and prognosis factors.
@nl
prefLabel
SULFs in human neoplasia: implication as progression and prognosis factors.
@en
SULFs in human neoplasia: implication as progression and prognosis factors.
@nl
P2093
P2860
P356
P1476
SULFs in human neoplasia: implication as progression and prognosis factors
@en
P2093
Bernard Klein
Caroline Bret
P2860
P2888
P356
10.1186/1479-5876-9-72
P577
2011-05-21T00:00:00Z
P5875
P6179
1019852120